Jennifer DUGAN STOCKS,Christopher EVANS,Seung HWANG,Susan M. DALLABRIDA
申请号：
US15499357
公开号：
US20170312289A1
申请日:
2017.04.27
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourettes syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.
